Research into new types of medicine and treatments are essential for improving health and deal with diseases. Who do you think should fund these researches: private companies, individuals or governments?

Health undoubtedly plays the most crucial role in human life.

Therefore

,

research

into medical developments are needed when it comes to enhancing people’s well-being and curing diseases. As far as it is concerned, the financial responsibility of

such

research

should be assumed by pharmaceutical enterprises rather than individuals and

goverments

the organization that is the governing authority of a political unit

governments

. Thanks to the advent of medicine and treatments,

life expectancy

Suggestion

the life expectancy

is prolonged and many lives are saved from serious illnesses.

Moreover

, with the discovery of new diseases these recent years, the task of improving

healthcare

Suggestion

health care

must be prioritized and proper investment needs careful consideration.

Although

residents seem to benefit the most from better medicine, they should not be responsible for funding medical

research

. It would be unfair if the wealthy contribute more money than others, whereas the poor and low-income group are unable to pay. The choice of state funding is

also

ineffective, as national budget has to cover a multitude of issues.

For example

, in the

coronavirus

epidemic, many countries pay for citizens’ hospital fees and provide basic needs during quarantine, which means the money allocated

on

Suggestion

for

to

medical

research

would be reduced considerably. As a consequence, the study of medication should be funded by private sectors. It usually requires immense capital, and companies can bare

such

huge expenses.

This

means that the pressure on nations would be reduced, and undeveloped ones would remain

finacially

from a financial point of view

financially

sound. Another merit is that private sectors

are specialized

Suggestion

specialize

in certain areas.

In other words

, pharmaceutical ones mainly concentrate on health-related issues.

Therefore

, when

research

into therapies are supported by

entreprises

a purposeful or industrious undertaking (especially one that requires effort or boldness)

enterprises

entrepreneurs

, they will be developed in full potential.

However

, the drawback is that companies often compete in their

marketpalce

the world of commercial activity where goods and services are bought and sold

marketplace

to gain profit, so governments and individuals should serve as observers. By doing so, people are protected from the abuses of businesses holding a dominant position. In conclusion, due to the importance of medical studies, non-state-run

entreprises

a purposeful or industrious undertaking (especially one that requires effort or boldness)

enterprises

should take on the funding and assure of ethical and productive outcomes.